Esculetin Inhibits Cancer Cell Glycolysis by Binding Tumor PGK2, GPD2, and GPI
Open Access
- 27 March 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 379
Abstract
Glycolysis can improve the tolerance of tissue cells to hypoxia, and its intermediates provide raw materials for the synthesis and metabolism of the tumor cells. If it can inhibit the activity of glycolysis-related enzymes and control the energy metabolism of tumor, it can be targeted for the treatment of malignant tumor. The target proteins phosphoglycerate kinase 2 (PGK2), glycerol-3-phosphate dehydrogenase (GPD2), and glucose-6-phosphate isomerase (GPI) were screened by combining transcriptome, proteomics, and reverse docking. We detected the binding constant of the active compound using microscale thermophoresis (MST). It was found that esculetin bound well with three potential target proteins. Esculetin significantly inhibited the rate of glycolysis, manifested by differences of cellular lactate production and glucose consumption in HepG2 cells with or without esculetin. It was found that GPD2 bound strongly to GPI, revealing the direct interaction between the two glycolysis-related proteins. Animal tests have further demonstrated that esculetin may have anticancer effects by affecting the activity of PGK2, GPD2, and GPI. The results of this study demonstrated that esculetin can affect the glucose metabolism by binding to glycolytic proteins, thus playing an anti-tumor role, and these proteins which have direct interactions are potential novel targets for tumor treatment by esculetin.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 55 references indexed in Scilit:
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue MetabolomicsCancer Research, 2013
- Tumor glycolysis as a target for cancer therapy: progress and prospectsMolecular Cancer, 2013
- Phosphatidylinositol 4,5-Bisphosphate Increases Ca2+ Affinity of Synaptotagmin-1 by 40-foldJournal of Biological Chemistry, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseasesNucleic Acids Research, 2011
- The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 proteinTrends in Cell Biology, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Network pharmacologyNature Biotechnology, 2007
- A 1.8 Å resolution structure of pig muscle 3-phosphoglycerate kinase with bound MgADP and 3-phosphoglycerate in open conformation: new insight into the role of the nucleotide in domain closure11Edited by R. HuberJournal of Molecular Biology, 2001
- A bisubstrate analog induces unexpected conformational changes in phosphoglycerate kinase from Trypanosoma bruceiJournal of Molecular Biology, 1998